Table 1.

Baseline characteristics of modified intent‐to‐treat population

Characteristics	EPCs (n = 5), n (%)	BMSCs (n = 5), n (%)	Placebo (n = 6), n (%)	p value
Age, years	50.80 ± 14.11	49.40 ± 10.85	52.83 ± 14.95	.915
Male	4 (80.0)	4 (80.0)	5 (83.3)	.986
Married	5 (100.0)	5 (100.0)	6 (100.0)
Body mass index, kg/m2	25.57 ± 3.83	23.08 ± 3.66	22.33 ± 1.73	.278
Allergic	1 (20.0)	0 (0.0)	0 (0.0)	.309
Time of cells culture	40.80 ± 11.43	27.00 ± 7.17		.342
Risk factors
Smoking	2 (40.0)	2 (40.0)	2 (33.3)	.965
Alcohol use	1 (20.0)	1 (20.0)	0 (0.0))	.504
Hypertension	3 (60.0)	4 (80.0)	1 (16.7)	.09
Dyslipidemia	0 (0.0)	0 (0.0)	0 (0.0)
Diabetes	0 (0.0)	0 (0.0)	0 (0.0)
Coronary artery disease	0 (0.0)	0 (0.0)	0 (0.0)
Atrial fibrillation	2 (40.0)	1 (0.0)	1 (0.0)	.641
COPD	0 (0.0)	0 (0.0)	0 (0.0)
TIA	0 (0.0)	0 (0.0)	0 (0.0)
Stroke mechanisms
Atherosclerotic	3 (60.0)	4 (80.0)	5 (83.3)	.641
Cardioembolic	2 (40.0)	1 (20.0)	1 (16.7)	.641
Cryptogenic	0 (0.0)	0 (0.0)	0 (0.0)
Treatment
Thrombolytics	0 (0.0)	0 (0.0)	0 (0.0)
Drugs	AP(3); AC(2)	AP(3); AC(2)	AP(4); AC(2)
mRS on 7th day	3.40 ± 0.89	4.00 ± 1.22	3.67 ± 0.82	.636
NIHSS on 7th day	12.20 ± 4.92	17.60 ± 5.59	15.50 ± 3.02	.632
Barthel index on 7th day	39.00 ± 24.60	27.00 ± 30.74	25.00 ± 20.00	.203
SSS on 7th day	28.00 ± 17.38	18.20 ± 13.50	19.33 ± 10.39	.483

Abbreviations: AC, anticoagulant; AP, antiplatelet agent; BMSCs, bone marrow stromal cells; bpm, beats per minute; COPD, chronic obstructive pulmonary disease; DBP, diastolic blood pressure; EPCs, endothelial progenitor cells; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood; SSS, Scandinavia Stroke Scale; TIA, transient ischemic attack.